Natural Alternatives International Inc (NAII) stock
NAIINasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends June 30
$0.90−0.00 (-0.11%)
Close on Nov 18, 2026Market cap $19.90MP/E –Yield –
Natural Alternatives International ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Natural Alternatives International's ebitda for the twelve months ending Jun 30, 2026 was -$14.04M. For fiscal 2026 it was -$14.04M. The highest annual figure on record is $18.01M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$14.04M | – |
| FY2025 | Jun 30, 2025 | -$4.10M | – |
| FY2024 | Jun 30, 2024 | -$3.89M | -143.4% |
| FY2023 | Jun 30, 2023 | $8.96M | -49.8% |
| FY2022 | Jun 30, 2022 | $17.84M | -0.9% |
| FY2021 | Jun 30, 2021 | $18.01M | +635.1% |
| FY2020 | Jun 30, 2020 | $2.45M | -74.0% |
| FY2019 | Jun 30, 2019 | $9.43M | -24.2% |
| FY2018 | Jun 30, 2018 | $12.44M | +2.9% |
| FY2017 | Jun 30, 2017 | $12.09M | -13.9% |
| FY2016 | Jun 30, 2016 | $14.03M | +112.9% |
| FY2015 | Jun 30, 2015 | $6.59M | +16.0% |
| FY2014 | Jun 30, 2014 | $5.68M | +9.5% |
| FY2013 | Jun 30, 2013 | $5.19M | -43.7% |
| FY2012 | Jun 30, 2012 | $9.22M | +66.1% |
| FY2011 | Jun 30, 2011 | $5.55M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$11.99M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$2.82M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$681.00K | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $1.45M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$784.00K | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$961.00K | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$1.65M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$709.00K | -217.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$1.32M | -130.1% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$854.00K | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$2.32M | -165.0% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $604.00K | -75.8% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $4.37M | -5.4% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$1.48M | -133.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $3.57M | +3.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $2.50M | -53.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $4.62M | +2.2% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $4.44M | +14.9% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $3.46M | -47.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $5.32M | +74.5% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $4.52M | +48.1% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $3.86M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $6.58M | +288.7% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $3.05M | +232.4% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $3.06M | +2232.1% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$3.21M | -216.2% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $1.69M | -43.8% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $917.00K | -73.9% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $131.00K | -96.3% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $2.77M | -15.3% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $3.01M | -1.0% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $3.52M | +35.2% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $3.53M | +29.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $3.27M | +98.5% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $3.04M | -18.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $2.60M | -34.9% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $2.73M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $1.65M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $3.71M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $3.99M | – |
See a number that looks wrong?